Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Mar 15, 2025; 17(3): 102187
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.102187
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.102187
Figure 7 HepG2 and Huh7 cell viability assay.
A: Effects of tetrahydrocurcumin (THC) on HepG2 cell viability at 24, 48, and 72 hours; B: Effects of THC on the viability of Huh7 cells. Seven experimental groups were included: Control group (0 μmol/L THC), THC (20, 40, 60, 80, 100, and 120 μmol/L). Data are presented as mean ± SD, n = 3. P < 0.05 vs the control group. THC: Tetrahydrocurcumin.
- Citation: Bao ZC, Liu ZD, Zhang Y, Dai HJ, Jia H, Ren F, Li N, Zhao L, Wang YW, Lv SY, Zhang Y. To investigate the effect and mechanism of tetrahydrocurcumin on hepatocellular carcinoma based on phosphoinositide 3-kinases/AKT signaling pathway. World J Gastrointest Oncol 2025; 17(3): 102187
- URL: https://www.wjgnet.com/1948-5204/full/v17/i3/102187.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i3.102187